Related Experiment Video

Updated: Apr 19, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma

Lei Yu1, Luting Zhou2, Yu Cheng1

  • 1Department of Infectious Disease, The Fourth Hospital of Harbin Medical University Harbin 150001, Heilongjiang, China.

American Journal of Cancer Research
|December 19, 2014
PubMed

Insights

MicroRNAs (miRNAs) are key in cancer. This study found increased miR-543 in liver cancer, promoting tumor growth and invasion by targeting PAQR3, suggesting miR-543 as a potential therapeutic target for hepatocellular carcinoma (HCC).

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs implicated in cancer, acting as oncogenes or tumor suppressors.
  • Deregulation of miRNA expression is increasingly recognized as a contributor to hepatocarcinogenesis (liver cancer development).

Purpose of the Study:

  • To investigate the role of miR-543 in hepatocellular carcinoma (HCC).
  • To identify the molecular targets and functional impact of miR-543 in liver cancer progression.

Main Methods:

  • Quantitative analysis of miR-543 and PAQR3 expression in clinical HCC tissues and cell lines.
  • Functional assays to assess the effect of miR-543 overexpression on HepG2 cell proliferation and invasion.
  • Fluorescent reporter assays and Western blot to validate PAQR3 as a direct target of miR-543.

Main Results:

  • miR-543 levels were significantly elevated in HCC tissues and cell lines compared to normal controls.
  • Forced expression of miR-543 enhanced the proliferative and invasive capabilities of HepG2 cells.
  • PAQR3 was identified as a direct target of miR-543, with its expression inversely correlated to miR-543 levels in HCC.
  • PAQR3 levels were found to be significantly decreased in HCC tissues and cell lines.

Conclusions:

  • miR-543 acts as an oncogenic miRNA in HCC by promoting cell proliferation and invasion.
  • The downregulation of PAQR3 by miR-543 contributes to hepatocarcinogenesis.
  • miR-543 represents a potential diagnostic biomarker and therapeutic target for HCC.
Keywords:
PAQR3hepatocellular carcinomamiR-543oncogene

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

536
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K